EKG Labs is excited to announce that we will be attending E&L USA 2018 from May 7-9 in Bethesda, Maryland. As a leader in the pharmaceutical and medical device testing field, EKG continues to attend, present, and exhibit at key industry conferences throughout the year. Notably, EKG will be returning to Philadelphia in September for PharmaED’s 5th Annual Transdermal and Intradermal Drug Delivery Systems. At this conference, EKG’s Dr. Xiao Jia will be presenting “Regulatory and Experimental Considerations for Extractable and Leachable Analysis of Microneedle Patches: A Case Study”.
Throughout 2018 EKG Labs has been traveling the country, sharing our expertise while also gaining knowledge from other industry leaders. This year, we have already attended Extractables, Leachables, & Elemental Impurities 2018, which was held by PharmaED at the end of March in Philadelphia, and the Medical Device Technology Exchange (MDTX) Conference and Exhibition held at the beginning of April in New Jersey. Dr. Allen Kesselring (Chief Science Officer at EKG Labs) presented at both conferences. Dr. Kesselring presented “USP <661> and USP <661.1>/<661.2>—A Review of Compendia Based Polymer Extractable and Chemical Safety Assessment” in Philadelphia and co-presented “Material and Assembly Method Selection for Safe, Reliable, and Cost-Effective Medical Device Manufacturing” at MDTX. If you would like to talk with us more about these topics or would like to obtain a copy of either presentation, please let us know.
EKG Labs is committed to attending crucial conferences in our field. We highly value sharing our knowledge and experiences with the broader scientific community and find it important to continue to learn from other industry experts and thought leaders, in order to stay on top of the latest regulations and procedures.
One of our favorite elements of these conferences is the opportunity to meet both current and prospective clients face-to-face. When not in a session, you can be sure to find us exploring the exhibit halls and networking over coffee. If you would like to meet with Dr. Kesselring or our CEO, Ms. Katie Grayson, at E&L USA 2018 to discuss your extractable/leachable questions or any other analytical needs, please click here. We’ll see you there!
About EKG Labs
Our analytical services support product development, regulatory filings, and analytical chemistry investigations.
Some of our services include:
- Extractables and Leachables Analysis
- Impurity Identification
- Method Development and Validation
To find out how EKG Labs can help you with your product development and regulatory needs, contact us at 810-354-5229.